Patents by Inventor Alessio Porta

Alessio Porta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE PREPARATION OF PANOBINOSTAT
    Publication number: 20230070370
    Abstract: The present invention relates to a new process for the preparation of Panobinostat and intermediates thereof.
    Type: Application
    Filed: February 25, 2021
    Publication date: March 9, 2023
    Applicants: FLAMMA SPA, UNIVERSITÀ DEGLI STUDI DI PAVIA
    Inventors: Massimiliano ANDREOLI, Teresa BASILE, Alessio PORTA, Giuseppe ZANONI, Roberto FANELLI, Massimo VERZINI
  • Metallocene compounds and labeled molecules comprising the same for in vivo imaging
    Patent number: 9399077
    Abstract: The present invention concerns compounds and methods of labeling peptides or other molecules with 18F or 19F or any other suitable radionuclide of use, for example, in PET or NMR in vivo imaging. A targeting molecule such as a protein or a peptide is linked to a substituted metallocene complex which is reacted with the 1gF or 19F shortly before performing the PET or NMR in vivo imaging on the patient. The labeled molecule is then used for targeting a cell, tissue, organ or pathogen to be imaged or detected.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: July 26, 2016
    Assignee: Aptenia S.r.l.
    Inventors: Guiseppe Zanoni, Alessio Porta, Marco Pazzi, Andrea Gandini, Wolfgang Karl-Diether Brill
  • Metallocene Compounds and Labeled Molecules Comprising the Same for In Vivo Imaging
    Publication number: 20160008495
    Abstract: The present invention concerns compounds and methods of labeling peptides or other molecules with 18F or 19F or any other suitable radionuclide of use, for example, in PET or NMR in vivo imaging. A targeting molecule such as a protein or a peptide is linked to a substituted metallocene complex which is reacted with the 1gF or 19F shortly before performing the PET or NMR in vivo imaging on the patient. The labeled molecule is then used for targeting a cell, tissue, organ or pathogen to be imaged or detected.
    Type: Application
    Filed: March 5, 2014
    Publication date: January 14, 2016
    Inventors: Guiseppe Zanoni, Alessio Porta, Marco Pazzi, Andrea Gandini, Wolfgang Karl-Diether Brill
  • PROCESS FOR THE PREPARATION OF PROSTAGLANDIN DERIVATIVES
    Publication number: 20120016136
    Abstract: The invention concerns a new process for the preparation of prostaglandin derivatives, in particular prostaglandin F2? derivatives, for example bimatoprost, latanoprost and travoprost, the new intermediates of said process and their use in the preparation of prostagblandin derivatives.
    Type: Application
    Filed: February 18, 2010
    Publication date: January 19, 2012
    Inventors: Giancarlo Biffi, Alessandro D'Alfonso, Lazzaro Feliciani, Alessio Porta, Giovanni Vidari, Enrico Viscardi, Giuseppe Zanoni
  • ESTERIFICATION PROCESS OF PROSTAGLANDINS AND ANALOGUES THEREOF
    Publication number: 20110124064
    Abstract: The invention relates to a process for enzymatically catalyzed esterification of prostaglandins or analogues thereof.
    Type: Application
    Filed: May 8, 2009
    Publication date: May 26, 2011
    Inventors: Giancarlo Biffi, Lazzaro Feliciani, Alessandro D'Alfonso, Alessio Porta, Giuseppe Zanoni